{
    "clinical_study": {
        "@rank": "102344", 
        "acronym": "AMP", 
        "arm_group": [
            {
                "arm_group_label": "acupoint-meridian group", 
                "arm_group_type": "Experimental", 
                "description": "Apply traditional acupuncture to prevent the migraine attack according to TCM theory"
            }, 
            {
                "arm_group_label": "sham-acupoint group", 
                "arm_group_type": "Other", 
                "description": "sham-acupoint will be penetrated for migraine prophylaxis."
            }, 
            {
                "arm_group_label": "waiting list", 
                "arm_group_type": "No Intervention", 
                "description": "No acupuncture nor other methods will be conducted in this group."
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: Acupuncture obtains an abiding effect on migraine prophylaxis Design: A\n      open-label randomized controlled trial. 249 participants will be included. Three arms:\n      acupuncture in acupoint-meridian\uff0c non-acupoint-meridian group, and waiting list."
        }, 
        "brief_title": "Acupuncture for Migraine Prophylaxis", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Migraine Without Aura", 
            "Unilateral Headache"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders", 
                "Migraine without Aura"
            ]
        }, 
        "detailed_description": {
            "textblock": "Aim: to attest the abiding efficacy and safety of acupuncture for migraine prophylaxis\n      Design: A open-label randomized controlled trial will be performed in Chengdu, Hunan and\n      Chongqing province. Two hundred and forty-three participants will be randomly assign to\n      acupoint-meridian group, non-acupoint-meridian group, and wait-and-see group. Each\n      participants will receive 20 sessions of acupuncture in 4 weeks, with a duration of 30\n      minutes in a session. After all the treatments was accomplished, there will be 5 times\n      follow-ups in the impending every 4 weeks. The primary outcome is frequency of migraine\n      attacks 16 weeks after inclusion. Secondary outcomes include frequency of migraine attacks\n      at the 4th and 24th week, headache severity, MSQ(Migraine Specific Quality of Life\n      Questionnaire MSQ Version2.1), etc."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age of a subject is between 18 and 65 years old(initially occured beneath the age of\n             50), male or female;\n\n          -  in accordance with diagnosis of migraine without aura in International Classification\n             of Headache Disorders, ICHD-2, by IHS;\n\n          -  2 to 8 times attack per month in recent 3 months, with each period beyond 15 days;\n\n          -  with migraine history for over 1 year;\n\n          -  be able and willing to finish the headache diary in baseline ;\n\n          -  informed consent form must be signed by patient or lineal relative;\n\n        Exclusion Criteria\uff1a\n\n          -  Patients who are unconscious, psychotic.\n\n          -  Patients with aggravating tumor and other serious consumptive disease, and who are\n             subject to infection and bleeding.\n\n          -  With serious primary illness or disease of cardiovascular, liver, renal,\n             gastrointestinal, hematological systems and so on.\n\n          -  Pregnant women or women in lactation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "249", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687660", 
            "org_study_id": "2012CB518501-2"
        }, 
        "intervention": {
            "arm_group_label": [
                "acupoint-meridian group", 
                "sham-acupoint group"
            ], 
            "description": "apply acupuncture to prevent the migraine attack", 
            "intervention_name": "acupuncture", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "acupuncture", 
            "migraine prophylaxis"
        ], 
        "lastchanged_date": "October 22, 2013", 
        "location": {
            "contact": {
                "email": "acuresearch@126.com", 
                "last_name": "Liang Fan-rong, MD", 
                "phone": "86-13438151411"
            }, 
            "facility": {
                "address": {
                    "city": "Chengdu", 
                    "country": "China", 
                    "state": "Sichuan", 
                    "zip": "610075"
                }, 
                "name": "Chengdu University of TCM"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment", 
        "other_outcome": [
            {
                "description": "to observe the change of MSQ", 
                "measure": "MSQ(Migraine Specific Quality of Life Questionnaire MSQ Version2.1)", 
                "safety_issue": "Yes", 
                "time_frame": "the day of inclusion and 4th week after inclusion"
            }, 
            {
                "description": "an outcome to indicate the expectation of patient towards acupuncture treatment for migraine", 
                "measure": "acupuncture expectation scale", 
                "safety_issue": "Yes", 
                "time_frame": "1 day"
            }
        ], 
        "overall_contact": {
            "last_name": "Li Ying, professor", 
            "phone": "13708095607"
        }, 
        "overall_official": {
            "affiliation": "Chengdu University of Traditional Chinese Medicine", 
            "last_name": "Fanrong Liang, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Science and Technology", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "to assess the frequency of migraine attacks at the 16th week after inclusion", 
            "measure": "frequency of migraine attacks", 
            "safety_issue": "Yes", 
            "time_frame": "16th week after inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687660"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chengdu University of Traditional Chinese Medicine", 
            "investigator_full_name": "973-2", 
            "investigator_title": "Chengdu University of Traditional Chinese Medicine", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "to assess the frequency of migraine attacks at the 4th and 24th week respectively", 
                "measure": "frequency of migraine attacks", 
                "safety_issue": "Yes", 
                "time_frame": "4th and 24th week after inclusion"
            }, 
            {
                "description": "to evaluate the change of severity of headache", 
                "measure": "headache severity", 
                "safety_issue": "Yes", 
                "time_frame": "0 day, 4th, 8th, 12th, 16th, 20th, 24th week after inclusion"
            }
        ], 
        "source": "Chengdu University of Traditional Chinese Medicine", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Hunan University of Traditional Chinese Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chongqing Medical University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "973-2", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}